Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-239240 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,528
Total Value
$50,004.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 22, 2026 | Exercise/Conversion | 2,176 | $3.98 | $8,660.48 | 64,547 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 22, 2026 | Sale | 2,176 | $19.00 | $41,344.00 | 62,371 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 22, 2026 | Exercise/Conversion | 2,176 | $0.00 | $0.00 | 37,824 | Direct | โ | View Details |